One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.

Cao D, Vranckx P, Valgimigli M, Sartori S, Angiolillo DJ, Bangalore S, Bhatt DL, Feng Y, Ge J, Hermiller J, Makkar RR, Neumann FJ, Saito S, Picon H, Toelg R, Maksoud A, Chehab BM, Choi JW, Campo G, De la Torre Hernandez JM, Krucoff MW, Kunadian V, Sardella G, Spirito A, Thiele H, Varenne O, Vogel B, Zhou Y, Windecker S, Mehran R

Open source

DOI
10.4244/eij-d-23-00658
Published
2024 May 20
Container
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4244/eij-d-23-00658,
  title = {One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.},
  author = {Cao D and Vranckx P and Valgimigli M and Sartori S and Angiolillo DJ and Bangalore S and Bhatt DL and Feng Y and Ge J and Hermiller J and Makkar RR and Neumann FJ and Saito S and Picon H and Toelg R and Maksoud A and Chehab BM and Choi JW and Campo G and De la Torre Hernandez JM and Krucoff MW and Kunadian V and Sardella G and Spirito A and Thiele H and Varenne O and Vogel B and Zhou Y and Windecker S and Mehran R},
  year = {2024},
  journal = {EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  doi = {10.4244/eij-d-23-00658},
  url = {https://doi.org/10.4244/eij-d-23-00658}
}

RIS

TY  - JOUR
TI  - One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.
AU  - Cao D
AU  - Vranckx P
AU  - Valgimigli M
AU  - Sartori S
AU  - Angiolillo DJ
AU  - Bangalore S
AU  - Bhatt DL
AU  - Feng Y
AU  - Ge J
AU  - Hermiller J
AU  - Makkar RR
AU  - Neumann FJ
AU  - Saito S
AU  - Picon H
AU  - Toelg R
AU  - Maksoud A
AU  - Chehab BM
AU  - Choi JW
AU  - Campo G
AU  - De la Torre Hernandez JM
AU  - Krucoff MW
AU  - Kunadian V
AU  - Sardella G
AU  - Spirito A
AU  - Thiele H
AU  - Varenne O
AU  - Vogel B
AU  - Zhou Y
AU  - Windecker S
AU  - Mehran R
PY  - 2024
JO  - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
DO  - 10.4244/eij-d-23-00658
UR  - https://doi.org/10.4244/eij-d-23-00658
ER  - 

APA

D, C., P, V., M, V., S, S., DJ, A., S, B., DL, B., Y, F., J, G., J, H., RR, M., FJ, N., S, S., H, P., R, T., A, M., BM, C., JW, C., G, C., JM, D. L. T. H., MW, K., V, K., G, S., A, S., H, T., O, V., B, V., Y, Z., S, W., & R, M. (2024). One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. https://doi.org/10.4244/eij-d-23-00658

Source records